
Bristol-Myers Squibb (US)


Despite consolidation in the healthcare industry, Bristol-Myers
Squibb has remained on the sidelines, waiting to make its move and quietly sharpening its focus on the pharmaceutical sector, and particularly on the biopharma sector. Once the world's #1 drug company, it has steadily been pushed down the rankings by mergers or aggressive growth among its
competitors. During the 1990s, it sold off several of its non-core lines, followed in 2001 by its central Clairol
business (to Procter & Gamble) as well as half of its medical devices portfolio, in order to
concentrate on medicines. Several other non-core units were sold in 2008 and 2009, most significantly the Mead Johnson nutritionals division. Because of its size, BMS is regarded as a potential takeover target. The group entered tentative merger negotiations in 2007 with
Sanofi-Aventis,
the developer of its best-selling product, Plavix, which alone accounted for around a third of revenues in 2011. However, no agreement was reached. Plavix lost its patent towards the end of 2012, creating a significant challenge for BMS's future performance.
Which agencies handle advertising for Bristol-Myers Squibb? Find
out more from the Account Assignments database.
Who are the competitors of Bristol-Myers Squibb? See Pharmaceutical Sector index for other companies
Subscribers only:
Adbrands profile
Account assignments and selected regional contact information
Adbrands Company Profiles provide a detailed analysis of the history and current operations of
leading advertisers, agencies and brands worldwide, and include a critical summary which identifies key strengths and
weaknesses. Adbrands Account Assignments tracks account management for the world's leading brands and companies, including
details of which advertising agency handles which accounts in which countries for major markets.


Subscribers may access the following website links:
Bristol-Myers Squibb website

Plavix |
Reyataz |
Abilify |
Atripla |
Sprycel |
Erbitux |
Ixempra |
Sustiva |
Avapro |
Pravachol |
Coumadin |
Onglyza |

Bristol-Myers Squibb Worldwide
Click HERE to subscribe to Adbrands.net and access
the profile and website links
Adbrands.net. All rights reserved © Mind Advertising Ltd
1998-2013
|